Inverse association of mortality and body mass index in patients with left ventricular systolic dysfunction of both ischemic and non‐ischemic etiologies

Obesity is a worldwide epidemic that has been associated with poor outcomes. Previous studies have demonstrated an inverse relationship between body mass index (BMI) and outcomes, the 'obesity paradox', in several diseases.

• Publication year

  2021

• Venue

  Clinical Cardiology

• Publication date

  2021-03-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/clc.23556PMID 33675050PMCID 8027570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inverse association of mortality and body mass index in patients with left ventricular systolic dysfunction of both ischemic and non‐ischemic etiologies

  2021cited by this paper
• Impact of Diabetes Mellitus on Mortality and Hospitalization in Patients With Mild-to-Moderate Cardiomyopathy.

  2020cited by this paper
• Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia.

  2020cited by this paper
• Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

  2018cited by this paper
• Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis

  2018cited by this paper
• Productivity loss due to overweight and obesity: a systematic review of indirect costs

  2017cited by this paper
• The ‘obesity paradox’ may not be a paradox at all

  2017cited by this paper
• 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cited by this paper
• Body-mass index and cause-specific mortality in 900 000 adults : collaborative analyses of 57 prospective studies

  2017cited by this paper
• Interaction between cardiovascular risk factors and body mass index and 10-year incidence of cardiovascular disease, cancer death, and overall mortality.

  2017cited by this paper
• Structural Bias in Studies of Cardiovascular Disease: Let's Not Be Fooled by the "Obesity Paradox".

  2017cited by this paper
• Re: Collider Bias Is Only a Partial Explanation for the Obesity Paradox.

  2017cited by this paper
• No benefit from the obesity paradox for diabetic patients with heart failure

  2016cited by this paper
• Global Public Health Burden of Heart Failure.

  2016cited by this paper
• Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.

  2016cited by this paper
• Body Mass Index, the Most Widely Used But Also Widely Criticized Index: Would a Criterion Standard Measure of Total Body Fat Be a Better Predictor of Cardiovascular Disease Mortality?

  2016cited by this paper
• Collider Bias Is Only a Partial Explanation for the Obesity Paradox

  2016cited by this paper
• Obesity and the obesity paradox in heart failure.

  2015cited by this paper
• Obesity Paradox: Origin and best way to assess severity in patients with systolic HF

  2015cited by this paper
• The direct and indirect costs of both overweight and obesity: a systematic review

  2014cited by this paper
• Obesity paradox in end-stage kidney disease patients.

  2014cited by this paper
• Obesity and the obesity paradox in heart failure.

  2014cited by this paper
• Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox.

  2014cited by this paper
• The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data

  2014cited by this paper
• Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: a report from the ET-CHD registry.

  2013cited by this paper
• The metabolic basis for the obesity paradox in heart failure

  2013cited by this paper
• Relation of body mass index to mortality among patients with percutaneous coronary intervention in the drug-eluting stent era: a systematic review and meta-analysis.

  2013cited by this paper
• Role of adipokines in cardiovascular disease.

  2013cited by this paper
• Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure.

  2013cited by this paper
• Obesity Paradox Does Exist

  2013cited by this paper
• The obesity paradox in elderly patients with heart failure: analysis of nutritional status.

  2012cited by this paper
• Sarcopenic obesity: A Critical appraisal of the current evidence.

  2012cited by this paper
• The obesity paradox in men versus women with systolic heart failure.

  2012cited by this paper
• Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association

  2011cited by this paper
• Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship.

  2010cited by this paper
• Association of Multiple Anthropometrics of Overweight and Obesity With Incident Heart Failure: The Atherosclerosis Risk in Communities Study

  2009cited by this paper
• Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

  2009cited by this paper
• Annual medical spending attributable to obesity: payer-and service-specific estimates.

  2009cited by this paper
• Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

  2008cited by this paper
• The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction.

  2007cited by this paper
• Obesity as a prognostic factor in chronic symptomatic heart failure.

  2005cited by this paper
• Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function.

  2005cited by this paper
• Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

  2003cited by this paper
• Body composition and prognosis in chronic systolic heart failure: the obesity paradox.

  2002cited by this paper
• The relationship between obesity and mortality in patients with heart failure.

  2001cited by this paper
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

  2000cited by this paper
• Wasting as independent risk factor for mortality in chronic heart failure.

  1997cited by this paper
• Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation.

  1990cited by this paper
• Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.

  1989cited by this paper

• Investigation of Syntax II Score and Neutrophil/Lymphocyte Levels in Non-ST Elevation Myocardial Infarctions

  2023cites this paper
• Outcomes after elective abdominal aortic aneurysm repair have improved over time in patients on dialysis.

  2022cites this paper
• Inverse association of mortality and body mass index in patients with left ventricular systolic dysfunction of both ischemic and non‐ischemic etiologies

  2021cites this paper